1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in the United Kingdom

Biotechnology in the United Kingdom

  • January 2016
  • -
  • MarketLine
  • -
  • 35 pages

Introduction

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Kingdom biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The UK biotechnology market is expected to generate total revenues of $10.7bn in 2015, representing a compound annual growth rate (CAGR) of 6.6% between 2011 and 2015.

- The medical/healthcare segment is expected to be the market's most lucrative in 2015, with total revenues of $7.1bn, equivalent to 66.4% of the market's overall value.

- Attracting investment is a key priority in the UK market in order to allow start-up ventures to succeed. The atmosphere for investment is not as strong as in the US where many specialist investors operate but signs are still good for the market. Nevertheless, the volatile nature of the industry ensures that future growth is by no means guaranteed.

Features

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts

- Macroeconomic indicators provide insight into general trends within the United Kingdom economy

Key Questions Answered

- What was the size of the United Kingdom biotechnology market by value in 2015?

- What will be the size of the United Kingdom biotechnology market in 2020?

- What factors are affecting the strength of competition in the United Kingdom biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the United Kingdom's biotechnology market?

Table Of Contents

Biotechnology in the United Kingdom
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
AstraZeneca PLC 19
GE Healthcare 22
Novartis AG 23
Sanofi SA 27
Macroeconomic Indicators 30
Country Data 30
Methodology 32
Industry associations 33
Related MarketLine research 33
Appendix 34
About MarketLine 34

List of Tables
Table 1: United Kingdom biotechnology industry value: $ billion, 2011-15(e)
Table 2: United Kingdom biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: United Kingdom biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: United Kingdom biotechnology industry value forecast: $ billion, 2015-20
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: GE Healthcare: key facts
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Sanofi SA: key facts
Table 13: Sanofi SA: key financials ($)
Table 14: Sanofi SA: key financials (€)
Table 15: Sanofi SA: key financial ratios
Table 16: United Kingdom size of population (million), 2011-15
Table 17: United Kingdom gdp (constant 2005 prices, $ billion), 2011-15
Table 18: United Kingdom gdp (current prices, $ billion), 2011-15
Table 19: United Kingdom inflation, 2011-15
Table 20: United Kingdom consumer price index (absolute), 2011-15
Table 21: United Kingdom exchange rate, 2011-15

List of Figures
Figure 1: United Kingdom biotechnology industry value: $ billion, 2011-15(e)
Figure 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: United Kingdom biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2015
Figure 11: AstraZeneca PLC: revenues and profitability
Figure 12: AstraZeneca PLC: assets and liabilities
Figure 13: Novartis AG: revenues and profitability
Figure 14: Novartis AG: assets and liabilities
Figure 15: Sanofi SA: revenues and profitability
Figure 16: Sanofi SA: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sample Preparation Market by Product , Consumables ), Application , End Users  - Global Forecast to 2021

Sample Preparation Market by Product , Consumables ), Application , End Users - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves ...

Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

Trends In Gene Therapy

July 2016 $ 5 000

Download Unlimited Documents from Trusted Public Sources

Genomics Industry in the US

  • September 2016
    49 pages
  • DNA  

    DNA Sequencing  

    Genome Sequenci...  

  • United States  

View report >

Biotech Industry in Europe

  • September 2016
    6 pages
  • Biotech  

  • Europe  

    United States  

    World  

View report >

Biotechnology Industry in the UK

  • September 2016
    57 pages
  • Biotechnology  

  • United Kingdom  

View report >

Related Market Segments :

Biotechnology
Pharmaceutical
Vaccine
Healthcare

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.